SMi's 10th Annual Biosimilars Conference

Memo

10th annual event is the first global event taking place in London, UK. The event's focus is to highlight the current challenges in the biosimilars market and discuss current plans or developments to overcome these challenges.The biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.With the expiry dates of major patents fast approaching, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026, the question is what can current biosimilar producing companies do to join this market to benefit the patients, physicians and investors? BENEFITS OF ATTENDING- HEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers- DISCUSS the possible changes in regulatory approval of biosimilars in the UK post Brexit, and how this will impact market entry- EXPLORE the latest methods in use to maintain the relationship between stakeholders, doctors and patients, with the influence of governing bodies- REVIEW FDA regulations for the approval of Biosimilars and the latest approvals PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS - Tuesday 24th September 2019 WHO SHOULD ATTEND?Presidents, Vice Presidents, Managing Directors, Directors, Associate Directors, Chiefs, Heads, Principals, Managers and Analysts of:Biosimilar and Product Development , Commercialization, Market Access , Medical Affairs, Intellectual Property, Bioloigcs, Biopharmaceuticals, R&D, Generics, Biobetters, Business Development and Marketing, Drug Development, Clinical Trials, Immunogenicity Studies On Wednesday September 25, 2019 at 8:30 am (ends Thursday September 26, 2019 at 4:30 pm) Prices: Conference and 2 Workshops: GBP 2697.0Conference and 1 Workshop: GBP 2098.0Conference Only: GBP 1499.02 Workshops: GBP 1198.01 Workshop Only: GBP 599.0Promotional Literature Distribution: GBP 999.0Conference Documentations: GBP 499.0Conference Speaker Presentations: GBP 499.0 URLs: Tickets: https://go.evvnt.com/402419-1?pid=5569 Booking: https://go.evvnt.com/402419-2?pid=5569 Brochure: https://go.evvnt.com/402419-3?pid=5569 Inquiries: https://go.evvnt.com/402419-4?pid=5569 Speakers: Chaired by Michel Mikhail, International Expert Regulatory Affairs, Global Expert Biosimilars, Anne Cook, Biologicals Quality Assessor, Medicines and Healthcare Products Regulatory Agency, Anne Cook, Biologicals Quality Assessor, Medicines and Healthcare Products Regulatory Agency, Louis Boon, CSO, Bioceros, Steiner Madsen, Medical Director, Norwegian Medicines Agency, Sue Naeyaert, Global Head Government Affairs, Fresenius Kabi, Aurelio Arias, Senior Thought Leadership Consultant, IQVIA Venue details: Copthorne Tara Hotel London Kensington, Scarsdale Place, London, W8 5SY, United Kingdom